- Home
- KYMR vs GTY Comparison
KYMR vs GTY Comparison
Compare KYMR & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- GTY
- Stock Information
- Founded
- KYMR 2015
- GTY 1955
- Country
- KYMR United States
- GTY United States
- Employees
- KYMR N/A
- GTY N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- GTY Real Estate
- Sector
- KYMR Health Care
- GTY Finance
- Exchange
- KYMR Nasdaq
- GTY Nasdaq
- Market Cap
- KYMR 1.8B
- GTY 1.6B
- IPO Year
- KYMR 2020
- GTY N/A
- Fundamental
- Price
- KYMR $30.53
- GTY $28.58
- Analyst Decision
- KYMR Buy
- GTY Buy
- Analyst Count
- KYMR 13
- GTY 6
- Target Price
- KYMR $56.69
- GTY $33.00
- AVG Volume (30 Days)
- KYMR 762.3K
- GTY 401.8K
- Earning Date
- KYMR 05-09-2025
- GTY 04-23-2025
- Dividend Yield
- KYMR N/A
- GTY 6.64%
- EPS Growth
- KYMR N/A
- GTY 2.68
- EPS
- KYMR N/A
- GTY 1.20
- Revenue
- KYMR $47,072,000.00
- GTY $206,751,000.00
- Revenue This Year
- KYMR $16.24
- GTY $7.70
- Revenue Next Year
- KYMR $22.41
- GTY $7.93
- P/E Ratio
- KYMR N/A
- GTY $23.59
- Revenue Growth
- KYMR N/A
- GTY 7.80
- 52 Week Low
- KYMR $19.45
- GTY $25.70
- 52 Week High
- KYMR $53.27
- GTY $33.85
- Technical
- Relative Strength Index (RSI)
- KYMR 53.88
- GTY 44.74
- Support Level
- KYMR $28.28
- GTY $27.99
- Resistance Level
- KYMR $35.98
- GTY $28.45
- Average True Range (ATR)
- KYMR 2.14
- GTY 0.55
- MACD
- KYMR 0.01
- GTY 0.12
- Stochastic Oscillator
- KYMR 50.71
- GTY 58.59
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About GTY Getty Realty Corporation
Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.